Enter assignee name

% Expired Patents = 37.5

EPO Patents = 6

Forward Citations = 140

Loading Chart...

3 inventors (with patents filed for the assignee):

Kathleen D Danenberg (14 out of 26 patents)

Glenda G Anderson (1 out of 4 patents)

Craig Stephens (1 out of 1 patent)

16 patents: Sort by Forward Citations

1. 8977506 - Systems and methods for detecting biological features (2015-03-10),

2. 8728763 - Methods, primers, probes and kits useful for the detection of BRAF mutations (2014-05-20),

3. 8586311 - Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression (2013-11-19),

4. 8026062 - Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors (2011-09-27),

5. 7732144 - [object Object] (2010-06-08),

6. 7560543 - [object Object] (2009-07-14),

7. 7138507 - Method of determining a chemotherapeutic regimen based on glutathione-s transferase pi expression (2006-11-21),

8. 7132238 - Method of determining a chemotherapeutic regimen based on ERCC1 expression (2006-11-07),

9. 7049059 - Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression (2006-05-23),

10. 6956111 - Method of determining dihydropyrimidine dehydrogenase gene expression (2005-10-18),

11. 6905821 - Method of determining Dihydropyrimidine dehydrogenase gene expression (2005-06-14),

12. 6686155 - Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression (2004-02-03),

13. 6602670 - Method of determining a chemotherapeutic regimen based on ERCC1 expression (2003-08-05),

14. 6582919 - Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates (2003-06-24),

15. 6573052 - Method of determining a chemotherapeutic regimen based on ERCCI expression (2003-06-03),

Response Genetics, Inc. is a global leader in the development and sale of molecular diagnostic testing services for cancer. With expertise in oncology genetics, the company provides innovative tests and research services to help healthcare professionals make more informed treatment decisions. By analyzing the genetic profile of tumors, Response Genetics aims to improve patient outcomes and contribute to precision medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

16 Patents

#128 in Los Angeles, CA

#4,763 in California

#19,887 in US

#37,739 in the World

Los Angeles, CA, United States of America

Response Genetics, Inc.

Forward Citations = 140

3 inventors:

Kathleen D Danenberg (14 out of 26 patents)

Glenda G Anderson (1 out of 4 patents)

Craig Stephens (1 out of 1 patent)

Please report any incorrect information to [email protected]